Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Am J Transplant. 2020 Sep 25;21(3):1238–1254. doi: 10.1111/ajt.16283

Table 1: Patient characteristics of all ITx patients and among rejection patients.

Table displaying total ITx patient characteristics, including details for the mild rejection and moderate-severe rejection group compared against the control group. P-values calculated using Chi-square test or Fisher’s exact test where appropriate.

Total Population Rejection Population
P-value Control (n=134) Rejection (n=130) P-value (vs control) Mild Rejection (n=44) P-value (vs control) Moderate-Severe Rejection (n=86)
Age at Transplantation (N) .0002 .003 .002
Adult 54 82 29 53
Pediatric 80 48 15 33
Sex (Male / Female) (N) .028 83 / 51 63 / 67 .029 19 / 25 .11 44 / 42
Race/Ethnicity (N)
White .26 68 75 .08 29 .69 46
Black/African American .28 42 33 .09 8 .72 25
Other .83 24 22 .76 7 .93 15
Transplant Type (N) .055 .22 .075
Isolated Intestinal Transplant 71 84 28 56
Combined Liver or Multi Visceral Transplant 63 46 16 30
Etiology (N)
Short Gut Syndrome .51 93 95 .19 35 .95 60
Motility / Malabsorption .15 31 21 .31 7 .22 14
Tumor .36 5 8 .64 1 .16 7
Other .72 5 6 .64 1 .47 5
1-year / 3-year graft survival (%) .42 / .079 88% / 75% 85% / 65% .76 / .56 86% / 71% .36 / .056 84% / 63%
1 -year / 3-year patient survival (%) .61 / .24 89% / 76% 87% / 69% .65 / .68 86% / 73% .69 / .18 87% / 68%